Personal genomes, quantitative dynamic omics and personalized medicine

Quantitative Biology
George I Mias, Michael P Snyder

Abstract

The rapid technological developments following the Human Genome Project have made possible the availability of personalized genomes. As the focus now shifts from characterizing genomes to making personalized disease associations, in combination with the availability of other omics technologies, the next big push will be not only to obtain a personalized genome, but to quantitatively follow other omics. This will include transcriptomes, proteomes, metabolomes, antibodyomes, and new emerging technologies, enabling the profiling of thousands of molecular components in individuals. Furthermore, omics profiling performed longitudinally can probe the temporal patterns associated with both molecular changes and associated physiological health and disease states. Such data necessitates the development of computational methodology to not only handle and descriptively assess such data, but also construct quantitative biological models. Here we describe the availability of personal genomes and developing omics technologies that can be brought together for personalized implementations and how these novel integrated approaches may effectively provide a precise personalized medicine that focuses on not only characterization and treatment but...Continue Reading

Associated Clinical Trials

References

Nov 1, 1996·Analytical Biochemistry·M RonaghiP Nyrén
Aug 15, 1998·Science·M RonaghiP Nyrén
Feb 18, 1999·Molecular and Cellular Biology·S P GygiR Aebersold
Dec 11, 1999·Nucleic Acids Research·M Kanehisa, S Goto
Jan 11, 2000·Nucleic Acids Research·S T SherryK Sirotkin
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Feb 28, 2002·Lancet·Emanuel F PetricoinLance A Liotta
Mar 5, 2002·Nature Medicine·William H RobinsonPaul J Utz
Mar 1, 2003·Nature Biotechnology·Matthias Mann, Ole N Jensen
Mar 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael P WashburnJohn R Yates
Mar 14, 2003·Nature·Ruedi Aebersold, Matthias Mann
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ido BraslavskyStephen R Quake
Jun 7, 2003·The Journal of Infectious Diseases·Ruedi Aebersold
Jun 26, 2003·Nucleic Acids Research·Pauline C Ng, Steven Henikoff
Jul 3, 2003·Journal of the American Society for Mass Spectrometry·Ruedi Aebersold
Jul 23, 2003·Nature Biotechnology·Junmin PengSteven P Gygi
Nov 1, 2003·Science·Kayoko YamadaJoseph R Ecker
Nov 5, 2003·Proteomics·William H RobinsonPaul J Utz
Feb 21, 2004·Bioinformatics·Robertson Craig, Ronald C Beavis
Feb 28, 2004·Bioinformatics·M ReichJ P Mesirov
May 28, 2004·Nature·William E Evans, Mary V Relling
Jul 2, 2004·Nature Reviews. Cancer·Julian L Griffin, John P Shockcor
Sep 24, 2004·Molecular & Cellular Proteomics : MCP·Philip L RossDarryl J Pappin
Oct 6, 2004·Genome Biology·Robert C GentlemanJianhua Zhang
Oct 12, 2004·Journal of Proteome Research·Lewis Y GeerStephen H Bryant
Oct 22, 2004·Nature·UNKNOWN International Human Genome Sequencing Consortium
Dec 21, 2004·Nucleic Acids Research·G Joshi-TopeL Stein
Mar 26, 2005·Science·Jill ChengThomas R Gingeras
May 17, 2005·BMC Bioinformatics·Miika AhdesmäkiOlli Yli-Harja
Oct 19, 2005·Nature Reviews. Molecular Cell Biology·John R YatesJohn J M Bergeron
Oct 29, 2005·Nature·UNKNOWN International HapMap Consortium
Dec 16, 2005·Pharmacogenomics·Simone GuptaRitushree Kukreti
Jan 13, 2006·Therapeutic Drug Monitoring·Colin A SmithGary Siuzdak

❮ Previous
Next ❯

Citations

Jan 25, 2014·Omics : a Journal of Integrative Biology·Eugene KolkerGregory Yandl
Oct 31, 2015·BioData Mining·Rajiv KarbhalUrmila Kulkarni-Kale
Jun 1, 2013·Advanced Drug Delivery Reviews·Rongling Wu, Zuoheng Wang
Jun 30, 2015·Scientific Reports·Angela MarcobalGeorge I Mias
Nov 1, 2015·Proteomics. Clinical Applications·Li ZhouEdouard C Nice
Jan 16, 2015·BMC Cancer·Frank Emmert-StreibPeter Hamilton
Aug 16, 2016·American Journal of Epidemiology·D Gayle DeBordPaul A Schulte
Nov 25, 2016·Scientific Reports·George I MiasChristina Christou
Sep 27, 2019·Human Genomics·UNKNOWN GUaRDIAN ConsortiumVinod Scaria
Jun 26, 2020·Pharmacogenomics and Personalized Medicine·Mohammad JamshidiMohammad-Reza Mahmoudian-Sani
Feb 3, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Behzad DamavandMohammad Reza Zali
Jan 30, 2018·Annals of the New York Academy of Sciences·Jordi Merino, Jose C Florez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of General Internal Medicine
Richard L Kravitz
The Journal of the Arkansas Medical Society
Issam Makhoul
Current Opinion in Pharmacology
Rui Chen, Michael Snyder
Annual Review of Pharmacology and Toxicology
Urs A MeyerMatthias Schwab
© 2021 Meta ULC. All rights reserved